Aerosolized antibiotics have advantages, drawbacks for ICU pneumonia

11/12/2012 | Medscape (free registration)

Using aerosolized antibiotics with ventilator-associated pneumonia patients can help avoid systemic antimicrobial exposure, but there remain drawbacks. In this interview, Michael E. Klepser from Ferris State University College of Pharmacy, in Big Rapids, Mich., says there is a risk for bacteremia in patients. "There's also considerable variation in the ability of different nebulizers to deliver a drug to the patient. As a result, each nebulizer–antibiotic combination may need to be evaluated to determine the stability and delivery characteristics," Klepser said.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN